OGN Short Volume
Organon & Co. (OGN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $3.60B, listed on NYSE, employing roughly 10,000 people, carrying a beta of 1.52 to the broader market. Organon & Co. Led by Joseph T. Morrissey Jr., public since 2021-05-14.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-09-30
- Short Volume
- 436.1K
- Total Volume
- 888.7K
- Short %
- 49.07%
- 30-Day Avg Short %
- 58.36%
Showing 30 days of FINRA short volume data for Organon & Co..
Learn how short volume is reported and how to read the data →
Frequently asked OGN short volume questions
- What is the daily OGN short volume?
- As of Sep 30, 2026, Organon & Co. (OGN) short volume is 436.1K shares against 888.7K total reported volume, or 49.07% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is OGN short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does OGN short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.